⌘K

Login Start Free

Home/Filings/4/0001493152-22-033681

4//SEC Filing

Trieu Vuong 4

Accession 0001493152-22-033681

CIK 0000908259other

View on SEC.gov Company Profile

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 9:00 AM ET

Size

6.1 KB

Accession

0001493152-22-033681

Insider Transaction Report

Form 4

Period: 2022-11-22

Oncotelic Therapeutics, Inc.OTLC

DirectorCHAIRMAN AND CEO10% Owner

Transactions

Purchase
Common Stock
2022-11-22$0.08/sh+70,000$5,600→ 90,438,021 total

Holdings

Common Stock
(indirect: By Autotelic, Inc.)
16,780,384
Common Stock
(indirect: By Spouse)
6,872,529

Documents

1 file

4
ownership.xmlPrimary

Issuer

Oncotelic Therapeutics, Inc.

CIK 0000908259

Entity typeother

Related Parties

1

filerCIK 0001587074

Filing Metadata

Form type: 4
Filed: Nov 24, 7:00 PM ET
Accepted: Nov 25, 9:00 AM ET
Size: 6.1 KB

View on SEC.gov